375 related articles for article (PubMed ID: 25043090)
1. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PD-L1 costimulatory pathway-induced mouse islet transplantation immune tolerance.
Li T; Ma R; Zhu JY; Wang FS; Huang L; Leng XS
Transplant Proc; 2015; 47(1):165-70. PubMed ID: 25645798
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
[TBL] [Abstract][Full Text] [Related]
4. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
[TBL] [Abstract][Full Text] [Related]
5. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
6. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.
Afaneh C; Muthukumar T; Lubetzky M; Ding R; Snopkowski C; Sharma VK; Seshan S; Dadhania D; Schwartz JE; Suthanthiran M
Transplantation; 2010 Dec; 90(12):1381-7. PubMed ID: 21079547
[TBL] [Abstract][Full Text] [Related]
7. OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection.
Wang YL; Fu YX; Zhu ZJ; Wang H; Shen ZY
Chin Med J (Engl); 2012 Nov; 125(21):3786-90. PubMed ID: 23106874
[TBL] [Abstract][Full Text] [Related]
8. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation In Vitro.
Li T; Ma R; Zhu JY
Transplant Proc; 2021 Mar; 53(2):716-723. PubMed ID: 33551184
[TBL] [Abstract][Full Text] [Related]
10. Blockade of both CD28/B7 and OX40/OX40L co-stimulatory signal pathways prolongs the survival of islet xenografts.
Wang GM; Yang Y; Jin YZ; Li AL; Hao J; Gao X; Xie SS
Transplant Proc; 2005 Dec; 37(10):4449-51. PubMed ID: 16387143
[TBL] [Abstract][Full Text] [Related]
11. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
Honkanen-Scott M; Johnson J; Hering B; Bansal-Pakala P
Transplant Proc; 2008 Mar; 40(2):483-5. PubMed ID: 18374109
[TBL] [Abstract][Full Text] [Related]
12. Blockade of OX40/OX40 ligand to decrease cytokine messenger RNA expression in acute renal allograft rejection in vitro.
Wang YL; Li G; Fu YX; Wang H; Shen ZY
Transplant Proc; 2013; 45(6):2565-8. PubMed ID: 23953582
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
[TBL] [Abstract][Full Text] [Related]
14. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival.
Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
Transplantation; 2009 Feb; 87(4):482-90. PubMed ID: 19307783
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model.
Mai G; del Rio ML; Tian J; Ramirez P; Buhler L; Rodriguez-Barbosa JI
Xenotransplantation; 2007 May; 14(3):243-8. PubMed ID: 17489865
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
17. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
[TBL] [Abstract][Full Text] [Related]
18. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
19. Use of genetically modified allograft to deliver local immunomodulatory molecule with minimal systemic toxicity in a rat model of allogeneic skin flap transplantation.
Fu S; Yang Y; Xiao B; Li Y; Yi CG; Xia W; Guo SZ
Transplant Proc; 2010 Nov; 42(9):3815-9. PubMed ID: 21094862
[TBL] [Abstract][Full Text] [Related]
20. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
